Improved anti-Candida activity of hydrogel containing tea tree oil-loaded solid lipid nanoparticles for the treatment of oropharyngeal candidiasis


 
 
 develop a hydrogel containing tea tree oil (TTO) encapsulated in solid lipid nanoparticles (SLNs) to treat oropharyngeal candidiasis.
 
 
 
 initially, the TTO chemical composition was evaluated. Next, SLNs containing TTO (TTO-SLNs) were produced and characterized. The TTO-SLNs were incorporated into a hydrogel, and the antifungal activity against Candida spp. was analysed. Finally, the ex vivo permeation was assessed.
 
 
 
 the chemical composition of TTO met ISO 4730:2017 standards. The TTO-SLNs were spherical and had a Z-average, PdI, ZP, and entrapment efficiency of 135.90 ± 6.65 nm, 0.19 ± 0.04 -31.07 ± 1.05 mV, and 92.74% ± 0.01%, respectively. Moreover, TTO-SLNs were stable (no changes in Z-average and PdI) for at least 120 days. In the cytotoxicity evaluation, the samples were considered cytotoxic at the following concentrations: TTO: 125-1,000 µg/mL, TTO-SLN: 348-5,568 µg/mL of TTO, and the control nanoparticle was not cytotoxic. Both TTO-SLNs and the hydrogel containing TTO-SLNs demonstrated fungicidal action against all Candida spp., while for TTO, it was found only against C. albicans. The percentage of TTO permeation was 70.52%.
 
 
 
 the hydrogel loaded with TTO-SLNs is a promising tool for TTO delivery, aiming at activity against C. albicans for the treatment of oropharyngeal candidiasis.
